651.0500 -16.75 (-2.51%)
NSE Jan 14, 2026 15:31 PM
Volume: 142.3K
 

651.05
-2.51%
Axis Direct
We retain our BUY rating on the stock with a target price of Rs 850/share, implying an upside potential of 19% from the CMP.
Number of FII/FPI investors increased from 104 to 115 in Sep 2025 qtr.
More from Healthcare Global Enterprises Ltd.
Recommended